1. TRANSGENE BIOTEK LTD
stock logo

TRANSGENE BIOTEK LTD Share Price

TRABI

₹6.85-₹0.15 (-2.14%) TodayLast updated on 08 May, 2024 | 03:29 PM IST
₹6.80₹7.29
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

What’s in news?

arrow
Empty state

No data available at the moment

Company overview

About

arrow

Market cap

Market Cap Switch₹53 Cr

Open

₹7.29

Close

₹7.00

Circuit range

₹7.35 - ₹6.65

Day range

₹6.80 - ₹7.29

Year range

₹2.94 - ₹12.46

Volume

66,808

Avg. traded

₹6.89

Revenue (12m)

₹0 Cr

TRANSGENE BIOTEK LTDTransgene Biotek Limited is an India-based biotechnology company. The Company is engaged in the research and development of vaccines, oncology and new drug delivery technologies. Its portfolio of products includes oncology, auto-immunity, drug delivery and biogenerics. The Company offers TrabiAAV, which is a platform for the delivery of micro ribonucleic acids (miRNAs), short hairpin RNA (ShRNAs), immunogens developing clinical significance in gene therapy and CRISPR/cas 9 technologies. Its monoclonal antibody therapy is the use of monoclonal antibodies to specifically bind to target cells. Its TrabiORAL is focused on delivering proteins and peptides orally for a variety of human diseases. Its TBL-1203, is used to strengthen cell-mediated immunity and complete elimination of the human immunodeficiency virus (HIV), without any need for retroviral drug therapy. Its Tacrolimus is a drug that suppresses the immune system and is mainly used to prevent rejection of transplanted organs.

Read more

TRANSGENE BIOTEK LTD Key indicators

arrow

52 week high

₹12.46

52 week low

₹2.94

P/E ratio

P/B ratio

4.89

ROE

--

ROCE

-57.49%

Dividend yield

--

Debt/Equity ratio

-2.11

EPS

-0.79

Learn more

Investment checklist: (2/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

-789.22%

Net profit margin

0%

ROE

0%

ROA

-17.24%

ROCE

-57.49%

Learn more

TRANSGENE BIOTEK LTD Shareholder returns

arrow

1 day

-2.76%

1 week

-1.12%

1 month

-8.21%

3 months

-34.88%

1 year

+127.10%

3 years

+54.39%

5 years

+57.85%

Revenue statement

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Cash flow

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Balance sheet

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

TRANSGENE BIOTEK LTD Share Price history

arrow
DayOpenCloseDay’s change
Tue, May 7 2024
₹7.08
₹7.00
-1.14%
Mon, May 6 2024
₹7.24
₹7.04
-2.84%
Fri, May 3 2024
₹7.17
₹7.24
+0.97%
Thu, May 2 2024
₹7.11
₹7.07
-0.57%
Tue, Apr 30 2024
₹7.37
₹7.08
-4.10%
Mon, Apr 29 2024
₹7.20
₹7.36
+2.17%
Fri, Apr 26 2024
₹7.56
₹7.12
-6.18%
Thu, Apr 25 2024
₹7.70
₹7.48
-2.94%

Shareholding info

arrow

Promoters (23.64%)

Mutual Funds (0%)

Retail and other (76.36%)

Foreign institutions-FII (0%)

Other domestic institutions (0%)

Retail and other

Learn more

Events

Empty state

No data available at the moment

Frequently asked questions